Pre-clinical comparison of approaches to increasing the immunogenicity of CA125 (MUC16) DNA vaccines

被引：0
|
作者：
Ragupathi, Govind
Koide, Fusataka
Yin, Beatrice Wt
Lloyd, Kenneth O.
Hannaman, Drew
Livingston, Philip O.
机构：
[1] Mem Sloan Kettering, New York, NY USA
[2] Ichor Med Syst Inc, San Diego, CA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1406
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
    Williams, Kristina A.
    Terry, Kathryn L.
    Tworoger, Shelley S.
    Vitonis, Allison F.
    Titus, Linda J.
    Cramer, Daniel W.
    PLOS ONE, 2014, 9 (02):
  • [22] The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity
    Saad, Hebatallah M.
    Tourky, Ghada F.
    Al-kuraishy, Hayder M.
    Al-Gareeb, Ali I.
    Khattab, Ahmed M.
    Elmasry, Sohaila A.
    Alsayegh, Abdulrahman A.
    Hakami, Zaki H.
    Alsulimani, Ahmad
    Sabatier, Jean-Marc
    Eid, Marwa W.
    Shaheen, Hazem M.
    Mohammed, Ali A.
    Batiha, Gaber El-Saber
    De Waard, Michel
    DIAGNOSTICS, 2022, 12 (12)
  • [23] MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling
    Giannakouros, Panagiota
    Comamala, Marina
    Matte, Isabelle
    Rancourt, Claudine
    Piche, Alain
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (01): : 219 - 230
  • [24] MUC16/CA125 synthetic lethal kinase screen for novel ovarian cancer targets
    Eng, Stephanie
    Robin, Manson
    Zhou, Qin C.
    Thapi, Dharmar O.
    Roslaes, Nestor
    Iasonos, Alexia
    Spriggs, David R.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [25] A biosensor for determination of the circulating biomarker CA125/MUC16 by Surface Plasmon Resonance Imaging
    Szymanska, B.
    Lukaszewski, Z.
    Hermanowicz-Szamatowicz, K.
    Gorodkiewicz, E.
    TALANTA, 2020, 206
  • [26] Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma
    Jiang, Kun
    Tan, Elaine
    Sayegh, Zena
    Centeno, Barbara
    Malafa, Mokenge
    Coppola, Domenico
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (09) : 620 - 623
  • [27] Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion
    Rump, A
    Morikawa, Y
    Tanaka, M
    Minami, S
    Umesaki, N
    Takeuchi, M
    Miyajima, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (10) : 9190 - 9198
  • [28] Immune cell bound MUC16 (CA125): A novel diagnostic marker for ovarian cancer
    Belisle, Jennifer A.
    Felder, Mildred
    Kapur, Arvinder
    Tyler, Chanel T.
    Connor, Joseph P.
    Patankar, Manish S.
    CANCER RESEARCH, 2011, 71
  • [29] Expression of MUC16/CA125 Is Associated with Impaired Survival in Patients with Surgically Resected Cholangiocarcinoma
    Kinzler, Maximilian N.
    Schulze, Falko
    Gretser, Steffen
    Abedin, Nada
    Trojan, Joerg
    Zeuzem, Stefan
    Schnitzbauer, Andreas A.
    Walter, Dirk
    Wild, Peter J.
    Bankov, Katrin
    CANCERS, 2022, 14 (19)
  • [30] Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16)
    Berman, Zach T.
    Moore, Lee J.
    Knudson, Kathleen E.
    Whelan, Rebecca J.
    TUMOR BIOLOGY, 2010, 31 (05) : 495 - 502
12345